Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

IDEXX Laboratories vs. Elanco: Which Pet Stock is a Better Buy?

Published 06/21/2021, 11:53 AM
Updated 06/21/2021, 12:30 PM
© Reuters.  IDEXX Laboratories vs. Elanco: Which Pet Stock is a Better Buy?

© Reuters. IDEXX Laboratories vs. Elanco: Which Pet Stock is a Better Buy?

The remote lifestyle forced by the COVID-19 pandemic boosted pet ownership over the past year. As a result, the pet industry has been faced with huge demand for pet food and medications. In response to this, pet companies are racing to develop quality food products and viable drugs and diagnostic products. We think these factors should help popular pet companies IDEXX Laboratories (IDXX) and Elanco (ELAN) deliver solid returns in the coming months. But let’s find out which of these stocks is a better buy now. Read on.IDEXX Laboratories, Inc. (IDXX) develops, manufactures and distributes products and provides services for the companion animal, veterinary, livestock and poultry, dairy and water testing markets worldwide. The company also sells portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Elanco Animal Health Incorporated (NYSE:ELAN) is an animal health care company that develops, manufactures, and markets products for companion and food animals. The company sells its products to third-party distributors, veterinarians, farm animal producers, and dairy farmers, and provides aquaculture operations.

The heightened adoption of companion animals during the pandemic and huge spending on pet food, toys, grooming and veterinary care allowed the U.S. pet industry to generate $103.60 billion in sale in 2020, which represents a 6.7% year-over-year improvement. The American Pet Products Association estimates the pet industry will generate $109.60 billion in sales this year. Also, rising investor optimism surrounding the industry is evident in the ProShares Pet Care ETF’s (PAWZ) 62.4% gains over the past year compared to the SPDR S&P 500 Trust ETF’s (SPY) 33.1% gains.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.